Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells

碩士 === 中國醫藥大學 === 營養學系碩士班 === 101 === Angiogenesis is invovled in the physiological processes including growth, development, wound healing, tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen, which is essential for endothelial cell survival...

Full description

Bibliographic Details
Main Authors: Siou-Yu Ye, 葉修渝
Other Authors: Haw-Wen Chen
Format: Others
Language:zh-TW
Published: 2013
Online Access:http://ndltd.ncl.edu.tw/handle/62488763891121932772
id ndltd-TW-101CMCH5513010
record_format oai_dc
spelling ndltd-TW-101CMCH55130102016-03-21T04:27:54Z http://ndltd.ncl.edu.tw/handle/62488763891121932772 Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells 二十二碳六烯酸(DHA)抑制血管內皮生長因子誘發血管新生機制之探討 Siou-Yu Ye 葉修渝 碩士 中國醫藥大學 營養學系碩士班 101 Angiogenesis is invovled in the physiological processes including growth, development, wound healing, tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen, which is essential for endothelial cell survival, proliferation, and migration. Docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, shows anti-carcinogenic potential both in vitro and in vivo. In this study, we investigated the molecular mechanism by which DHA down-regulates angiogenesis. We used HUVECs and fertilized chicken eggs as study models, and used chick chorioallantoic membrane (CAM) assay, MTT assay, Western blotting,wound healing assay, phosphatase activity assay and NO assay, to explore the anti-carcinogenic effect of DHA. The results showed that DHA, PD98059 (ERK inhibitor) and GW9508 (GPR120 agonist) inhibited VEGF-induced cell migration. Nevertheless, pretreatment with okadaic acid (OA, PP2A inhibitor) and S-Nitroso-N-acetyl-DL-penicillamine (SNAP, NO donor) reversed the cell migration inhibitory effect of DHA. VEGF induced angiogenesis was accompanied by phosphorylation of ERK and eNOS, as well as an increase in NO production. Treatment of HUVECs with DHA increased PP2A enzyme activity and decreased VEGF-induced phosphorylation of ERK and eNOS. However, pretreatment with OA significantly decreased DHA-induced PP2A enzyme activity and reversed the DHA inhibition of VEGF-induced ERK and eNOS phosphorylation. These results suggest that DHA abolishes VEGF-induced cell migratin via inhibition of VEGF-induced ERK/eNOS/NO signaling pathway and stimulation of PP2A activity. Taken together, anti-caricnogenic effect of DHA is at least in part by virture of its attenuation of cell migration which is essential for angiogenesis. Haw-Wen Chen 陳暉雯 2013 學位論文 ; thesis 67 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 中國醫藥大學 === 營養學系碩士班 === 101 === Angiogenesis is invovled in the physiological processes including growth, development, wound healing, tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen, which is essential for endothelial cell survival, proliferation, and migration. Docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, shows anti-carcinogenic potential both in vitro and in vivo. In this study, we investigated the molecular mechanism by which DHA down-regulates angiogenesis. We used HUVECs and fertilized chicken eggs as study models, and used chick chorioallantoic membrane (CAM) assay, MTT assay, Western blotting,wound healing assay, phosphatase activity assay and NO assay, to explore the anti-carcinogenic effect of DHA. The results showed that DHA, PD98059 (ERK inhibitor) and GW9508 (GPR120 agonist) inhibited VEGF-induced cell migration. Nevertheless, pretreatment with okadaic acid (OA, PP2A inhibitor) and S-Nitroso-N-acetyl-DL-penicillamine (SNAP, NO donor) reversed the cell migration inhibitory effect of DHA. VEGF induced angiogenesis was accompanied by phosphorylation of ERK and eNOS, as well as an increase in NO production. Treatment of HUVECs with DHA increased PP2A enzyme activity and decreased VEGF-induced phosphorylation of ERK and eNOS. However, pretreatment with OA significantly decreased DHA-induced PP2A enzyme activity and reversed the DHA inhibition of VEGF-induced ERK and eNOS phosphorylation. These results suggest that DHA abolishes VEGF-induced cell migratin via inhibition of VEGF-induced ERK/eNOS/NO signaling pathway and stimulation of PP2A activity. Taken together, anti-caricnogenic effect of DHA is at least in part by virture of its attenuation of cell migration which is essential for angiogenesis.
author2 Haw-Wen Chen
author_facet Haw-Wen Chen
Siou-Yu Ye
葉修渝
author Siou-Yu Ye
葉修渝
spellingShingle Siou-Yu Ye
葉修渝
Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells
author_sort Siou-Yu Ye
title Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells
title_short Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells
title_full Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells
title_fullStr Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells
title_full_unstemmed Docosahexaenoic Acid Inhibits VEGF-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells
title_sort docosahexaenoic acid inhibits vegf-induced angiogenesis in human umbilical vein endothelial cells
publishDate 2013
url http://ndltd.ncl.edu.tw/handle/62488763891121932772
work_keys_str_mv AT siouyuye docosahexaenoicacidinhibitsvegfinducedangiogenesisinhumanumbilicalveinendothelialcells
AT yèxiūyú docosahexaenoicacidinhibitsvegfinducedangiogenesisinhumanumbilicalveinendothelialcells
AT siouyuye èrshíèrtànliùxīsuāndhayìzhìxuèguǎnnèipíshēngzhǎngyīnziyòufāxuèguǎnxīnshēngjīzhìzhītàntǎo
AT yèxiūyú èrshíèrtànliùxīsuāndhayìzhìxuèguǎnnèipíshēngzhǎngyīnziyòufāxuèguǎnxīnshēngjīzhìzhītàntǎo
_version_ 1718209323605164032